Primary debulking surgery vs. interval debulking surgery for advanced ovarian cancer: review of the literature and meta-analysis-Reference-Cited by-同舟云学术

Primary debulking surgery vs. interval debulking surgery for advanced ovarian cancer: review of the literature and meta-analysis

Published:2019-07 Issue:4 Volume:110 Page:
ISSN:0026-4806
Container-title:Minerva Medica
language:
Short-container-title:Minerva Med

Author:

Chiofalo Benito,Bruni Simone,Certelli Camilla,Sperduti Isabella,Baiocco Ermelinda,Vizza Enrico

Publisher

Edizioni Minerva Medica

Subject

General Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R10Y2019N04A0330

Reference54 articles.

1. Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome

2. Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management

3. Cytogenetic analysis of epithelial ovarian cancer's stem cells: an overview on new diagnostic and therapeutic perspectives;Laganà AS;Eur J Gynaecol Oncol,2015

4. [Reflections on treatments for infertility and the possible occurrence of ovarian carcinomas];Ferranti G;Recenti Prog Med,2017

5. Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy;International Journal of Gynecologic Cancer;2024-08-07

2. Prognostic Impact of Tumor-Infiltrating Immune Cells on Efficacy of Neoadjuvant Chemotherapy in Patients with Advanced or Metastatic Ovarian Cancer: A Retrospective Study;Medical Science Monitor;2024-06-13

3. Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study;Frontiers in Oncology;2024-05-28

4. Economic Evaluation of Neoadjuvant Versus Adjuvant Chemotherapy in Cancer Treatment: A Systematic Review and Meta-Analysis;Value in Health Regional Issues;2024-05

5. Honokiol induces ferroptosis in ovarian cancer cells through the regulation of YAP by OTUB2;Journal of Obstetrics and Gynaecology Research;2024-03-13